Market Outlook

By 2035, the U.S. Orthopedic Implants Market is expected to reach approximately USD 56.08 billion, growing at a CAGR of 6.95% during the forecast period 2026–2035. The market was valued at USD 28.64 billion in 2025, with historical analysis from 2021 to 2024. Values in this report are expressed in USD billions.

The U.S. orthopedic implants industry is a clinically essential, procedure-driven market supported by aging demographics, high osteoarthritis prevalence, traumatic injury volumes, degenerative spine disease, sports-related soft-tissue damage, and the growing need for revision reconstruction. More than 61 million Americans were aged 65 or older in 2024, while diagnosed arthritis affected more than one-fifth of U.S. adults. Osteoarthritis alone affects approximately 33 million adults. These conditions create recurring demand for knee, hip, shoulder, spine, trauma, foot and ankle, hand and wrist, and sports medicine implants across inpatient and outpatient settings.

The market is shifting from standardized implant supply toward digitally enabled procedural ecosystems. Hospital and ambulatory surgery center buyers increasingly evaluate implants together with robotic planning, navigation, patient-specific instrumentation, 3D-printed porous structures, inventory logistics, sterile-pack efficiency, clinical education, and post-operative outcomes data. Implant vendors that can reduce operating-room time, improve component positioning, lower revision risk, and simplify tray burden are gaining stronger access to value analysis committees and enterprise contracts.

The historical market expanded from USD 21.89 billion in 2021 to USD 26.78 billion in 2024, supported by recovery in elective arthroplasty, strong trauma demand, higher spine procedure volumes, and accelerating migration of selected joint replacement procedures into hospital outpatient departments and ambulatory surgery centers. In 2025, the market reached USD 28.64 billion as procedure backlogs normalized, robotic-assisted reconstruction expanded, extremity portfolios attracted investment, and large manufacturers used acquisitions to strengthen foot and ankle, soft-tissue fixation, and personalized implant capabilities.

 

Introduction

According to the U.S. Orthopedic Implants Market Report, the industry is shaped by a combination of high musculoskeletal disease burden, advanced surgical infrastructure, strong orthopedic specialist networks, established Medicare and commercial reimbursement, and rapid innovation in materials and surgical enabling technology. Orthopedic care is implant-intensive because definitive treatment for end-stage joint degeneration, unstable fractures, spinal instability, deformity, and ligament or tendon failure often requires a permanent or bioresorbable implant. The United States also has a large base of academic medical centers, orthopedic specialty hospitals, level I trauma centers, integrated delivery networks, and physician-owned ambulatory surgery centers that can support premium technologies when clinical outcomes and episode economics are compelling.

The U.S. orthopedic implants market is not a single uniform category. It combines high-volume primary joint replacement, complex revision systems, spinal fixation, interbody devices, trauma plates and screws, intramedullary nails, fracture fixation, suture anchors, interference screws, extremity arthroplasty, sacroiliac fusion, patient-specific implants, and specialty reconstructive products. Revenue therefore reflects both recurring procedural demand and a meaningful innovation premium. Mature hip and knee systems provide a stable base, while shoulder, foot and ankle, sports medicine fixation, robotic-assisted arthroplasty, porous titanium, and minimally invasive spine platforms provide faster growth.

The addressable clinical infrastructure is substantial. The American Joint Replacement Registry now contains information on more than 4.4 million hip and knee procedures performed from 2012 through 2024 across all states and U.S. territories. Older-adult falls generate approximately 3 million emergency department visits and about 1 million hospitalizations annually, including nearly 319,000 hip-fracture hospitalizations. In spine, inpatient lumbar fusion volume reached more than 273,000 procedures in 2023. These demand pools create recurring implant utilization across elective reconstruction, emergency trauma, revision surgery, and chronic degenerative disease.

From 2026 to 2035, the most important strategic theme will be the separation of implant value from implant price. Hospitals will continue to apply price pressure to mature products, but they will pay for measurable workflow improvement, reliable supply, lower infection and revision risk, faster discharge, reduced instrumentation burden, and stronger patient-reported outcomes. Manufacturers that integrate implants with planning, navigation, robotics, data, clinical support, and reimbursement evidence will be better positioned than vendors selling isolated components.

 

Key Market Drivers: What’s Fueling the U.S. Orthopedic Implants Market Boom?

The first major driver is the scale and persistence of musculoskeletal disease. Diagnosed arthritis affects 21.3% of U.S. adults, and prevalence rises sharply with age. Osteoarthritis is the leading clinical pathway into hip and knee arthroplasty, while rotator cuff disease, degenerative disc disease, spinal stenosis, osteoporosis, and post-traumatic arthritis expand the addressable implant population. Because many of these conditions are progressive rather than episodic, the market benefits from a long pipeline of patients moving from conservative management to surgical intervention.

A second driver is demographic aging. The U.S. population aged 65 and older reached approximately 61.2 million in 2024 and represented 18.0% of the population. By the early 2030s, every baby boomer will be older than 65. This shift increases demand for primary joint replacement, hip-fracture fixation, shoulder arthroplasty, spinal decompression and fusion, and revision surgery. Aging also raises procedural complexity because more patients present with osteoporosis, obesity, diabetes, cardiovascular disease, or prior implants, increasing the need for advanced fixation and revision systems.

A third driver is the outpatient migration of orthopedic surgery. Medicare added total knee arthroplasty to the ambulatory surgery center covered procedure list in 2020 and total hip arthroplasty in 2021. Since then, commercially insured and selected Medicare patients have increasingly received joint replacement in outpatient departments and ASCs. This changes product requirements. Outpatient facilities favor efficient instrumentation, predictable implant availability, reduced tray counts, rapid-turn sterile processing, multimodal pain pathways, and implants that support same-day discharge.

A fourth driver is the economic importance of orthopedic service lines. Joint replacement, spine, trauma, and sports medicine procedures can generate material contribution margins, specialist referral volume, imaging demand, rehabilitation utilization, and regional brand value for health systems. Hospitals therefore protect high-performing orthopedic programs even under capital constraints. Procurement committees increasingly review implants through episode cost, operating-room utilization, revision burden, inventory carrying cost, vendor service, and reimbursement capture rather than purchase price alone.

A fifth driver is the growth of trauma and fragility fractures. Falls remain the leading cause of injury among older adults, and nearly 319,000 older Americans are hospitalized for hip fractures each year. Trauma implants are used under urgent conditions, making supply reliability and broad size availability critical. Demand is especially durable for intramedullary nails, locking plates, screws, external fixation, pelvic reconstruction, and fracture-management systems that can accommodate osteoporotic bone and complex anatomy.

A sixth driver is the competitive expansion of robotics, navigation, and patient-specific planning. Robotic-assisted knee and hip replacement has moved from early-adopter academic centers into community hospitals, orthopedic specialty facilities, and high-volume ASCs. The implant often becomes part of a longer-term platform decision because the robot, planning software, implant system, service agreement, and surgeon training are commercially linked. This creates an installed-base advantage for manufacturers that can convert enabling technology placements into recurring implant pull-through.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. orthopedic implants market is increasingly focused on fixation quality, personalization, workflow speed, and lifetime implant performance. The next competitive cycle is not simply about releasing another implant shape. It is about using advanced materials, digital planning, surgical automation, and outcomes data to improve component positioning, soft-tissue balance, osseointegration, fracture stability, and revision predictability.

Robotic-assisted reconstruction is one of the most visible innovation areas. Contemporary platforms support pre-operative planning, intraoperative bone preparation, implant alignment, gap assessment, and data capture. For hospitals, the investment case depends on procedure volume, surgeon recruitment, implant pull-through, length of stay, and the ability to standardize care pathways. For manufacturers, robotics can create durable account retention because switching implant systems may require new instruments, new training, and workflow redesign.

Additive manufacturing and porous metal technology are changing implant design. 3D printing enables complex lattice structures, patient-specific geometries, and porous surfaces designed to promote bone ingrowth. These capabilities are particularly relevant in revision arthroplasty, complex acetabular reconstruction, spinal interbody devices, shoulder glenoid augmentation, pelvic reconstruction, and foot and ankle surgery. The commercial value is highest when customization reduces operative improvisation or avoids more extensive bone removal.

Smart and sensor-enabled implants are emerging as a strategic category. Connected knee systems and implant-linked sensors can capture gait, range-of-motion, loading, or recovery data. Although adoption remains early, the long-term opportunity is significant because payers and providers increasingly want objective post-operative evidence. Sensor-enabled implants could support rehabilitation triage, earlier identification of abnormal recovery, and longitudinal outcomes measurement, but commercialization will depend on data utility, patient engagement, cybersecurity, and workflow integration.

Implant materials are also evolving. Titanium alloys remain important for spine, trauma, and porous reconstruction because of strength, corrosion resistance, and biocompatibility. Cobalt-chromium remains established in load-bearing joint components, ceramics support low-wear bearing surfaces, and highly cross-linked polyethylene continues to improve arthroplasty longevity. PEEK and radiolucent polymers are widely used in spine, while bioresorbable and composite materials are expanding in sports medicine and selected extremity procedures.

Manufacturers are raising the bar through evidence and service. U.S. buyers increasingly expect registry participation, patient-reported outcomes, revision-rate analysis, infection data, health-economic models, and transparent post-market surveillance. Commercial execution also matters. The winning supplier must provide implant availability, on-site case support, loaner inventory management, sterile processing coordination, surgeon education, and rapid response when a complex revision or trauma case requires non-standard components.

 

Segmentation Insights

The U.S. Orthopedic Implants Market is segmented on the basis of product category, application, end user, material type, and region.

 

By Product Category

Joint Reconstruction Implants

Joint reconstruction implants represent the largest product category and include primary and revision knee, hip, shoulder, elbow, ankle, and small-joint systems. Knee and hip implants provide the largest recurring revenue base because of procedure volume, established reimbursement, and replacement of end-stage arthritic joints. Growth is shifting toward cementless knee fixation, dual-mobility hip systems, reverse shoulder arthroplasty, partial knee replacement, robotic-compatible portfolios, and revision components designed for bone loss and instability.

Spinal Implants

Spinal implants include pedicle screws, rods, plates, interbody devices, cervical fixation, thoracolumbar systems, motion-preservation devices, vertebral augmentation, and sacroiliac fusion implants. Demand is supported by degenerative disc disease, spinal stenosis, deformity, instability, trauma, and revision surgery. Minimally invasive systems, expandable cages, porous titanium interbodies, navigation-compatible instruments, and robotic workflows are expanding value, while hospital scrutiny of implant pricing and surgeon preference remains intense.

Trauma and Craniomaxillofacial Implants

Trauma and craniomaxillofacial implants include plates, screws, intramedullary nails, external fixation, pelvic systems, fracture-specific devices, and craniofacial fixation. The category is clinically non-discretionary and benefits from emergency demand. Competitive advantage depends on breadth of sizes, rapid delivery, intuitive instrumentation, fixation in osteoporotic bone, and the ability to serve level I trauma centers and community hospitals with consistent inventory.

Sports Medicine and Soft-Tissue Fixation Implants

Sports medicine implants include suture anchors, interference screws, cortical buttons, meniscal repair devices, ligament augmentation, tendon fixation, and bioresorbable implants used in arthroscopic or minimally invasive procedures. Demand is supported by active populations, youth athletics, work-related injuries, and the preference to restore mobility. This category has attractive growth because procedure volumes are high, implant sizes are small, and innovation can materially improve fixation strength and surgical efficiency.

Extremity and Specialty Implants

Extremity and specialty implants cover foot and ankle reconstruction, hand and wrist fixation, small-joint arthroplasty, limb lengthening, sacroiliac fusion, and patient-specific reconstruction. This is a fragmented but fast-growing category. Manufacturers are investing in specialist sales teams, surgeon-designed systems, 3D-printed implants, and targeted acquisitions because extremity procedures can deliver above-market growth and are less commoditized than traditional hip and knee reconstruction.

 

By Application

Osteoarthritis and Degenerative Joint Disease

Osteoarthritis and degenerative joint disease form the largest application segment. The pathway includes progressive pain, reduced mobility, failed conservative therapy, and eventual joint replacement. Knee, hip, and shoulder systems dominate demand. Growth is supported by aging, obesity, longer life expectancy, and patient expectations for mobility. The segment also includes revision surgery when wear, loosening, instability, infection, or periprosthetic fracture compromises a prior implant.

Degenerative Spine Disease and Deformity

Degenerative spine disease and deformity include lumbar stenosis, spondylolisthesis, cervical disc disease, scoliosis, and instability. Implants support fusion, alignment restoration, decompression, and motion preservation. The application is economically important because case complexity and implant intensity can be high. Growth is strongest in minimally invasive surgery, expandable interbodies, adult deformity, navigation-assisted placement, and outpatient-appropriate cervical and lumbar procedures.

Fractures and Acute Trauma

Fractures and acute trauma require urgent fixation across the hip, femur, tibia, pelvis, shoulder, wrist, hand, ankle, and craniofacial anatomy. Hip fractures among older adults are a major demand driver, while motor vehicle incidents, workplace injuries, and sports trauma sustain broader volume. The segment favors companies with complete systems, dependable logistics, and strong trauma-representative coverage.

Sports Injuries and Soft-Tissue Repair

Sports injuries and soft-tissue repair include anterior cruciate ligament reconstruction, rotator cuff repair, labral repair, meniscal procedures, tendon reattachment, and ligament stabilization. Demand spans adolescents, working-age adults, professional athletes, and older active patients. Growth is supported by arthroscopic techniques, ambulatory migration, improved biologic fixation, and a broad range of suture-based and bioresorbable implant options.

Revision and Complex Reconstruction

Revision and complex reconstruction are high-value applications because they require specialized augments, cones, stems, cages, custom components, and extensive instrumentation. As the installed base of primary implants grows and patients live longer, revision demand will increase. Manufacturers with broad revision portfolios, rapid custom-design capability, and experienced field support can command strategic importance even when primary implant pricing is highly competitive.

 

By End User

Hospitals and Integrated Health Systems

Hospitals and integrated health systems are the dominant end users. They perform most complex joint reconstruction, spine, trauma, revision, and high-risk orthopedic procedures. Large systems negotiate enterprise agreements, reduce vendor counts, standardize implant families, and use value analysis committees to assess clinical evidence, supply reliability, and total episode cost. National and regional health systems can influence pricing across multiple states and often require manufacturers to provide data, training, inventory, and service commitments.

Ambulatory Surgery Centers

Ambulatory surgery centers are the fastest-growing end-user segment for selected primary hip and knee replacement, sports medicine, foot and ankle, hand, and lower-complexity spine procedures. ASCs prioritize predictable scheduling, rapid room turnover, low tray burden, bundled pricing, and same-day discharge. Vendors that offer compact instrument sets, direct delivery, procedure kits, and ASC-specific commercial models are positioned to gain share.

Orthopedic Specialty Hospitals and Physician-Owned Facilities

Orthopedic specialty hospitals and physician-owned facilities are high-volume users with strong procedural focus and tightly managed care pathways. These centers often adopt robotics, navigation, standardized implants, and enhanced recovery protocols earlier than general hospitals. Their concentrated surgeon base can accelerate conversion to a new platform, but purchasing decisions are highly sensitive to implant economics, efficiency, and physician alignment.

Academic Medical Centers and Trauma Centers

Academic medical centers and trauma centers are strategically important for complex revisions, deformity, oncology reconstruction, severe trauma, clinical trials, and surgeon training. They influence national practice patterns and generate evidence for new implants. These institutions require broad product depth and specialized technical support, but procurement is rigorous and often includes formal review of outcomes, conflicts of interest, and comparative value.

Orthopedic Clinics and Other Care Settings

Orthopedic clinics and other care settings influence implant selection through diagnosis, referral, pre-operative planning, and post-operative care. While implants are not usually purchased directly by clinics, large physician groups can shape hospital and ASC contracting. Vendor engagement increasingly includes digital planning, patient education, remote recovery tools, and practice-level analytics.

 

By Material Type

Titanium and Titanium Alloys

Titanium and titanium alloys are widely used in spine, trauma, extremities, and porous joint reconstruction. Their strength-to-weight ratio, corrosion resistance, biocompatibility, and compatibility with additive manufacturing make them central to next-generation implant design. Porous titanium is gaining share in interbody cages, acetabular components, tibial cones, shoulder augments, and custom reconstruction.

Cobalt-Chromium and Stainless-Steel Alloys

Cobalt-chromium remains important in load-bearing knee and hip components because of wear resistance and mechanical strength. Stainless steel retains relevance in trauma fixation and cost-sensitive systems. Growth is slower than titanium because buyers and designers increasingly favor lower-weight, porous, and imaging-compatible alternatives, but these metals remain deeply established in mature implant platforms.

Ceramic Materials

Ceramic materials are used primarily in hip bearings and selected specialty applications. Their low wear and favorable biocompatibility support use in younger or active patients when clinically appropriate. Ceramic-on-polyethylene combinations are an important premium option, although cost, brittleness concerns, and implant-system compatibility limit universal adoption.

Polymeric Materials

Polymeric materials include highly cross-linked polyethylene, PEEK, and other engineered polymers. Polyethylene is essential in knee and hip articulation, while PEEK is widely used in spinal interbody devices because of radiolucency and an elastic modulus closer to bone than metal. Material innovation focuses on wear reduction, imaging visibility, surface modification, and integration with porous or coated structures.

Bioresorbable, Composite, and Advanced Porous Materials

Bioresorbable and composite materials are gaining importance in sports medicine, trauma, and selected extremity procedures. Advanced porous structures, carbon-fiber composites, and biologically active coatings are being developed to improve fixation, reduce imaging artifact, or support tissue integration. Adoption depends on long-term evidence, manufacturing consistency, and surgeon confidence in mechanical performance.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Orthopedic Implants Market is geographically segmented into the South, West, Northeast, and Midwest. Regional performance differs according to population size, age distribution, arthritis and obesity burden, trauma volume, orthopedic surgeon density, academic-center concentration, hospital consolidation, ASC penetration, payer mix, and adoption of robotic and outpatient workflows. The South represented the largest market in 2025, while the West is expected to record the fastest growth through 2035. The Northeast remains the highest-acuity market on a per-case basis, and the Midwest provides durable demand with strong manufacturer and provider infrastructure.

South

The South was the dominant regional market, accounting for an estimated USD 10.60 billion in 2025. The region includes Texas, Florida, Georgia, North Carolina, Tennessee, South Carolina, Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, Virginia, Maryland, Delaware, West Virginia, and the District of Columbia. Its leadership is supported by large population centers, above-average population growth, a significant chronic disease burden, expanding Medicare populations, and rapid development of hospital and ASC capacity.

Texas is the largest state market in the region and is estimated at approximately USD 2.24 billion in 2025. Houston, Dallas–Fort Worth, Austin, and San Antonio support high-volume joint replacement, spine, trauma, and sports medicine programs. Texas also has a large number of integrated health systems and physician-owned surgical facilities. The state’s scale creates attractive opportunities for enterprise contracting, robotic platform placement, and regional trauma supply, but competition is intense and major systems exert substantial pricing leverage.

Florida is estimated at approximately USD 1.89 billion and is one of the country’s most important markets for hip, knee, shoulder, and fracture implants because of its older population. The state’s Medicare concentration supports joint replacement and fragility-fracture demand, while migration into outpatient settings is increasing the importance of ASC-compatible implant systems. South Florida, Tampa, Orlando, and Jacksonville are major procedure hubs.

North Carolina, Georgia, Tennessee, and Virginia are high-growth state markets. North Carolina is estimated at USD 0.74 billion, Georgia at USD 0.69 billion, Tennessee at USD 0.53 billion, and Virginia at USD 0.51 billion in 2025. These states benefit from population growth, strong academic centers, health-system expansion, and increasing outpatient orthopedic capacity. North Carolina and Tennessee also have important orthopedic research and manufacturing links.

Alabama, Mississippi, Louisiana, Kentucky, West Virginia, Arkansas, and Oklahoma have meaningful arthritis, obesity, fall, and trauma burdens. Their markets are smaller but clinically important. Advanced revisions and deformity procedures are concentrated in regional referral centers, while community hospitals require reliable trauma and primary reconstruction supply. Rural access constraints create demand for standardized systems, tele-supported planning, and distributor networks that can cover large geographic areas.

The South is projected to remain the largest region through 2035 and could exceed USD 21 billion under the report’s base forecast. Growth will be driven by aging, joint replacement, trauma, spine, extremity reconstruction, ASC expansion, and continued consolidation of regional health systems. Manufacturers will need differentiated contracting strategies for national systems, physician-owned facilities, and rural hospitals.

West

The West represented an estimated USD 6.59 billion in 2025 and is expected to grow faster than the national average. The region includes California, Washington, Arizona, Colorado, Oregon, Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii. Its growth profile is supported by technology adoption, large metropolitan health systems, an expanding older population in the Southwest, and strong interest in digital planning, robotics, minimally invasive spine, and personalized implants.

California is the largest Western state market and is estimated at approximately USD 2.67 billion in 2025. Los Angeles, San Diego, the San Francisco Bay Area, Sacramento, and the Central Valley create diverse demand across academic medicine, integrated delivery networks, community hospitals, trauma centers, and ASCs. California is also important for early adoption of navigation, 3D printing, sensor-enabled recovery, and value-based orthopedic pathways. However, labor costs, regulatory complexity, and aggressive payer contracting pressure suppliers to demonstrate operational value.

Arizona, Nevada, Colorado, and Utah are fast-growing markets because of population migration, aging, and expansion of specialty care. Arizona is estimated at USD 0.62 billion in 2025 and benefits from strong demand for joint reconstruction, spine, and trauma. Colorado and Utah combine integrated delivery networks with research-oriented providers, while Nevada’s growth is linked to expanding hospital capacity in Las Vegas and Reno. These states are attractive for new ASC development and robotic-assisted joint replacement.

Washington and Oregon show strong adoption of evidence-based care, digital integration, and enterprise procurement. Their major health systems often evaluate implants through standardized pathways and outcomes reporting. Idaho, Montana, Wyoming, Alaska, and New Mexico are smaller markets but require effective regional distribution and trauma coverage. Referral distances increase the value of systems that reduce complications and support predictable post-operative recovery.

By 2035, the West could approach USD 14 billion. Its share is expected to rise because of demographic growth, higher adoption of enabling technology, expansion of outpatient surgery, and demand for personalized or minimally invasive implants. The region will remain a strategic launch market for companies introducing robotic-compatible, 3D-printed, and data-enabled orthopedic platforms.

Northeast

The Northeast accounted for an estimated USD 6.30 billion in 2025. The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Maine, Vermont, New Hampshire, Rhode Island, and Delaware. It is characterized by dense specialist networks, leading academic medical centers, mature hospital infrastructure, high commercial insurance penetration in major metros, and a large installed base of orthopedic implants requiring revision and follow-up.

New York is the largest state market in the Northeast and is estimated at approximately USD 1.45 billion. New York City supports complex revision, spine, trauma, oncology reconstruction, and clinical trials, while Long Island, Westchester, Albany, Rochester, Syracuse, and Buffalo provide substantial community procedure volume. Procurement is highly structured, and vendors must navigate large health systems, group purchasing agreements, unionized operating environments, and rigorous evidence review.

Pennsylvania is estimated at USD 1.03 billion, New Jersey at USD 0.60 billion, and Massachusetts at USD 0.54 billion in 2025. Pennsylvania benefits from large health systems in Philadelphia and Pittsburgh and a substantial older population. New Jersey combines dense population with access to major academic centers. Massachusetts is influential because of its research, teaching hospitals, and early evaluation of advanced orthopedic technologies.

Connecticut, Rhode Island, New Hampshire, Vermont, and Maine are smaller but attractive markets for joint replacement, shoulder, spine, and outpatient procedures. Maine and Vermont have older population profiles that support arthroplasty and fracture demand. The region’s slower population growth limits volume expansion, but high procedure complexity, revision intensity, and premium technology adoption support value growth.

The Northeast is projected to approach USD 12 billion by 2035. Growth will remain below the West but profitable because of complex case mix, academic influence, and high adoption of advanced revision and reconstruction systems. Manufacturers that provide strong clinical evidence, registry support, and sophisticated contracting will perform best.

Midwest

The Midwest represented an estimated USD 5.15 billion in 2025. The region includes Illinois, Ohio, Michigan, Minnesota, Indiana, Wisconsin, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota. Demand is supported by established orthopedic programs, high chronic disease prevalence in several states, strong trauma networks, and a deep medtech manufacturing and clinical research ecosystem.

Illinois is estimated at USD 0.94 billion, Ohio at USD 0.82 billion, and Michigan at USD 0.59 billion in 2025. Chicago supports academic and community orthopedic volume across reconstruction, spine, trauma, and sports medicine. Ohio has multiple high-volume health systems and specialty centers. Michigan combines a strong surgical market with proximity to major implant manufacturers and technical talent.

Minnesota is estimated at approximately USD 0.47 billion and is strategically important because of its medical technology cluster and orthopedic expertise. Indiana, Wisconsin, and Missouri provide stable procedure volumes and broad community-hospital networks. Iowa, Kansas, Nebraska, North Dakota, and South Dakota are smaller markets where regional referral patterns, rural trauma coverage, and supply-chain reliability are especially important.

Midwestern buyers often emphasize service reliability, clinical education, and cost-effective standardization. Vendors that can reduce inventory duplication, support multi-hospital systems, and maintain rapid trauma response are well positioned. The region is also important for training, product development, and surgeon collaboration because of its concentration of orthopedic companies and research institutions.

The Midwest is projected to approach USD 9 billion by 2035. Growth will be steady rather than explosive, supported by aging, replacement procedures, trauma, and continued modernization of community orthopedic programs. The region will remain a dependable market for mature implants and a development base for new technologies.

 

Key Market Players

The U.S. Orthopedic Implants Competitive Landscape is consolidated in large joint reconstruction, spine, and trauma categories, but fragmented in extremities, sports medicine, sacroiliac fusion, patient-specific implants, and specialized fixation. Large companies compete through portfolio breadth, national contracting, robotics, navigation, surgeon education, and inventory scale. Specialized companies compete by solving a specific clinical or workflow problem and building deep relationships with focused surgeon groups.

Competition is increasingly platform-based. Implant share is influenced by the installed base of robots and navigation systems, instrument familiarity, sales representative quality, hospital conversion costs, registry outcomes, and the ability to support both primary and revision cases. Price remains important, but switching is difficult when surgeons, sterile processing teams, and operating-room staff are trained around a specific system.

The market is also entering a new portfolio-optimization cycle. Large manufacturers are separating mature businesses, acquiring high-growth extremity assets, and using targeted transactions to strengthen soft-tissue fixation, foot and ankle, 3D printing, and digital surgery. Over the forecast period, scale advantages will remain strong, but focused innovators can gain share where clinical differentiation is clear.

1. DePuy Synthes, a Johnson & Johnson MedTech business

2. Stryker Corporation

3. Zimmer Biomet Holdings

4. Smith+Nephew

5. Medtronic

6. Globus Medical

7. Enovis Corporation

8. Arthrex

9. Integra LifeSciences

10. Orthofix Medical

11. CONMED Corporation

12. Aesculap, a B. Braun company

13. Acumed, a Colson Medical company

14. Exactech

15. MicroPort Orthopedics

16. Corin Group

17. SI-BONE

18. Alphatec Holdings

19. Highridge Medical

20. restor3d

21. Treace Medical Concepts

22. Skeletal Dynamics

23. Tyber Medical

24. Curiteva

25. Aurora Spine

DePuy Synthes, Stryker, Zimmer Biomet, and Smith+Nephew hold leading positions in large-joint reconstruction and trauma. Medtronic, Globus Medical, Alphatec, Orthofix, Highridge Medical, and other specialists compete in spine. Arthrex and CONMED are influential in sports medicine, while Enovis, Acumed, Treace Medical Concepts, Skeletal Dynamics, restor3d, and other focused companies are expanding in extremities and specialized reconstruction.

Market share through 2035 will be influenced by procedure growth, U.S. sales-force execution, hospital contracting, robotic and navigation pull-through, supply reliability, product recalls, regulatory performance, surgeon training, and real-world outcomes. Companies that can demonstrate lower revision burden, faster operating-room workflow, and reliable outpatient pathways will be best positioned to defend premium pricing.

 

Recent Developments

Recent developments in the U.S. Orthopedic Implants Market show a clear shift toward focused portfolio strategies and high-growth extremity categories. In April 2025, Zimmer Biomet completed its acquisition of Paragon 28, strengthening its position in foot and ankle implants. The transaction reflects the strategic attractiveness of specialist portfolios that offer surgeon-specific products, differentiated fixation, and faster category growth than mature hip and knee markets.

In October 2025, Johnson & Johnson announced its intention to separate its Orthopaedics business into a standalone company operating as DePuy Synthes. The planned separation is strategically significant because DePuy Synthes is one of the largest orthopedic businesses globally. A focused structure could increase investment discipline, improve commercial execution, and intensify competition across joints, trauma, spine, sports medicine, and enabling technology.

Stryker completed the acquisition of Artelon in July 2024, adding synthetic soft-tissue fixation products for foot and ankle and sports medicine. This move illustrates how large orthopedic manufacturers are expanding beyond traditional metal implants into ligament and tendon reconstruction, biologically oriented fixation, and specialty procedures with strong ambulatory potential.

Enovis completed its acquisition of LimaCorporate in January 2024. The combination expanded Enovis in global reconstruction and added 3D-printed trabecular titanium, shoulder revision, and custom implant capabilities. The transaction strengthened competition in shoulder and extremity reconstruction and demonstrated the strategic value of additive manufacturing and patient-specific solutions.

The integration of Globus Medical and NuVasive continued to reshape the U.S. spine market through 2025. The combined platform links spinal implants, enabling technology, navigation, robotics, biologics, and procedural services. This increases pressure on smaller spine companies to differentiate through surgeon service, specialized implants, minimally invasive techniques, or attractive hospital economics.

Reimbursement policy is also evolving. The national CJR-X model is scheduled to begin in October 2027 and will expand mandatory episode-based accountability for lower-extremity joint replacement across inpatient and outpatient hospital settings. This will increase demand for implant and workflow solutions that support predictable outcomes, lower complications, coordinated post-acute care, and transparent episode economics.

 

Conclusion

The U.S. Orthopedic Implants Market Size & Share is positioned for sustained expansion from USD 28.64 billion in 2025 to USD 56.08 billion by 2035, supported by a 6.95% CAGR during the forecast period. The market’s long-term strength is grounded in arthritis prevalence, demographic aging, fracture burden, degenerative spine disease, outpatient migration, and the clinical necessity of implant-based reconstruction.

The most attractive growth opportunities will come from robotic-compatible joint reconstruction, shoulder and extremity implants, 3D-printed porous structures, minimally invasive spine, revision systems, sports medicine fixation, trauma implants for osteoporotic bone, and patient-specific reconstruction. Mature hip, knee, spine, and trauma categories will remain the largest value pools, but growth will depend increasingly on workflow, data, and total episode performance.

Regional opportunity will be led by the South because of population scale, aging, and expanding surgical infrastructure. The West will gain share through technology adoption and population growth. The Northeast will remain important for complex cases, research, and premium technology, while the Midwest will provide stable demand and deep industry infrastructure. California, Texas, Florida, New York, Pennsylvania, Illinois, Ohio, North Carolina, Georgia, Arizona, Michigan, New Jersey, and Massachusetts will be especially important state markets.

For clients evaluating this market, the central issue is not whether orthopedic implant demand will grow. The more important questions are which procedures will migrate outpatient, where robotics will create implant lock-in, how revision demand will evolve, which materials and designs will produce durable clinical value, and how procurement will respond to episode-based reimbursement. Companies that combine differentiated implants, dependable supply, workflow efficiency, clinical evidence, and flexible contracting will define the next decade of the U.S. orthopedic implants industry.

 

TABLE OF CONTENT

1. U.S. Orthopedic Implants Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.2.1. Included Orthopedic Implant Categories
1.2.2. Excluded Products and Adjacent Markets
1.2.3. Geographic Scope
1.2.4. Historical, Base Year, and Forecast Period
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Bottom-Up Market Estimation
1.3.6. Top-Down Market Validation
1.3.7. Procedure-Volume and Implant-Utilization Modeling
1.3.8. Analytical Frameworks & Forecasting Models
1.3.9. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Orthopedic Implant Manufacturers
1.6.2. Biomaterial, Component, and Contract Manufacturing Suppliers
1.6.3. Hospitals and Integrated Delivery Networks
1.6.4. Orthopedic Specialty Hospitals and Trauma Centers
1.6.5. Ambulatory Surgery Centers and Physician-Owned Facilities
1.6.6. Group Purchasing Organizations and Distributors
1.6.7. Orthopedic Surgeons and Clinical Decision-Makers
1.6.8. Payers, Regulators, and Reimbursement Authorities

What this section provides: This section defines the market boundary, included implant categories, study scope, methodology, assumptions, and stakeholder ecosystem so clients understand how the U.S. orthopedic implants market is measured, segmented, and validated.

2. U.S. Orthopedic Implants Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size and CAGR Summary
2.8. Highest-Revenue Product Categories
2.9. Fastest-Growing Clinical Applications
2.10. High-Growth State and Regional Opportunities
2.11. Competitive and Investment Highlights

What this section provides: This section gives decision-makers a concise view of market size, growth direction, implant demand, procedure-volume trends, competitive intensity, regional performance, and priority opportunity areas.

3. U.S. Orthopedic Implants Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Aging U.S. Population and Rising Musculoskeletal Disease Burden
3.1.2. High Prevalence of Osteoarthritis and Degenerative Joint Disease
3.1.3. Growth in Hip, Knee, and Shoulder Replacement Procedures
3.1.4. Rising Spine Surgery and Spinal Fusion Volumes
3.1.5. Increasing Trauma and Fragility-Fracture Burden
3.1.6. Migration of Orthopedic Procedures to Outpatient Settings
3.1.7. Expansion of Robotic-Assisted and Navigation-Guided Surgery
3.1.8. Growing Demand for Revision and Complex Reconstruction Implants
3.2. Restraints and Their Impact Analysis
3.2.1. High Implant and Procedure Costs
3.2.2. Implant Price Compression and Hospital Contracting Pressure
3.2.3. Reimbursement Pressure and Value Analysis Scrutiny
3.2.4. Product Recalls and Post-Market Safety Risks
3.2.5. Surgical-Site Infection and Revision Risk
3.2.6. Orthopedic Surgeon and Skilled Operating-Room Workforce Constraints
3.2.7. Dependence on Surgeon Preference and Vendor-Specific Instrumentation
3.3. Opportunities and Their Impact Analysis
3.3.1. Cementless and Robotic-Compatible Joint Reconstruction Implants
3.3.2. Shoulder, Foot and Ankle, and Extremity Implant Expansion
3.3.3. Outpatient Total Joint Replacement Implant Systems
3.3.4. 3D-Printed and Patient-Specific Orthopedic Implants
3.3.5. Smart and Sensor-Enabled Implant Platforms
3.3.6. Minimally Invasive Spine and Motion-Preservation Devices
3.3.7. Implants Designed for Osteoporotic Bone
3.3.8. Revision Arthroplasty and Complex Reconstruction Solutions
3.4. Challenges and Their Impact Analysis
3.4.1. Implant Commoditization in Mature Product Categories
3.4.2. Operating-Room Inventory and Instrument-Tray Complexity
3.4.3. Supply-Chain and Sterile Processing Constraints
3.4.4. Long-Term Clinical Evidence Requirements
3.4.5. Cybersecurity and Data Governance for Connected Implant Platforms
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.6.1. Implant Cost per Procedure
3.6.2. Operating-Room Time and Turnover Economics
3.6.3. Instrument-Tray and Sterile Processing Costs
3.6.4. Length-of-Stay and Same-Day Discharge Economics
3.6.5. Revision and Readmission Cost Impact
3.7. Hospital Capital Procurement Behavior Analysis
3.7.1. Robotic Platform Investment Decisions
3.7.2. Implant Pull-Through and Capital Placement Models
3.7.3. Surgeon Preference Versus Enterprise Standardization
3.7.4. Value Analysis Committee Evaluation Criteria
3.7.5. Multi-Year Implant Contracting and Vendor Consolidation

What this section provides: This section explains the demographic, clinical, reimbursement, technological, procurement, and operational forces shaping orthopedic implant demand, helping clients evaluate growth opportunities and execution risks.

4. U.S. Orthopedic Implants Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Implant Average Selling Price Analysis
4.5. Value Chain & Supply Chain Analysis
4.5.1. Raw Material and Alloy Suppliers
4.5.2. Implant Design and Engineering
4.5.3. Contract Manufacturing and Precision Machining
4.5.4. Additive Manufacturing and Surface Treatment
4.5.5. Sterilization, Packaging, and Distribution
4.5.6. Hospital, ASC, and Trauma-Center Delivery
4.6. Impact of Digitalization, Robotics, and Navigation
4.7. Application & Innovation Landscape
4.8. FDA Regulatory Framework Analysis
4.8.1. 510(k) Premarket Notification Pathway
4.8.2. Premarket Approval Pathway
4.8.3. De Novo Classification
4.8.4. Unique Device Identification and Post-Market Surveillance
4.8.5. Orthopedic Implant Recall and Safety Monitoring
4.9. CMS Reimbursement and Coverage Landscape
4.9.1. Inpatient Prospective Payment System
4.9.2. Hospital Outpatient Prospective Payment System
4.9.3. Ambulatory Surgery Center Reimbursement
4.9.4. Bundled Payment and Episode-Based Models
4.9.5. Comprehensive Care for Joint Replacement Models
4.10. Import/Export Restrictions & Tariff Impact
4.11. Government Initiatives and Musculoskeletal Health Programs
4.12. Impact of Escalating Geopolitical Tensions
4.13. Hospital Value Analysis Committee Decision Framework
4.13.1. Clinical Evidence Evaluation
4.13.2. Implant Price and Episode-Cost Assessment
4.13.3. Surgeon Preference Review
4.13.4. Supply Reliability and Inventory Evaluation
4.13.5. Outcomes and Revision-Rate Assessment

What this section provides: This section gives clients a complete view of regulation, reimbursement, pricing, manufacturing, supply chain, technology adoption, hospital procurement, and the external environment influencing the U.S. orthopedic implants market.

5. U.S. Orthopedic Implants Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Joint Reconstruction Implants
5.1.2.1. Knee Implants
5.1.2.1.1. Total Knee Replacement Implants
5.1.2.1.2. Partial Knee Replacement Implants
5.1.2.1.3. Revision Knee Implants
5.1.2.2. Hip Implants
5.1.2.2.1. Total Hip Replacement Implants
5.1.2.2.2. Partial Hip and Hemiarthroplasty Implants
5.1.2.2.3. Revision Hip Implants
5.1.2.3. Shoulder Implants
5.1.2.3.1. Anatomic Shoulder Implants
5.1.2.3.2. Reverse Shoulder Implants
5.1.2.3.3. Revision Shoulder Implants
5.1.2.4. Elbow Implants
5.1.2.5. Ankle Replacement Implants
5.1.2.6. Small-Joint Implants
5.1.3. Spinal Implants
5.1.3.1. Thoracolumbar Fixation Systems
5.1.3.2. Cervical Fixation Systems
5.1.3.3. Interbody Fusion Devices
5.1.3.4. Motion-Preservation Devices
5.1.3.5. Vertebral Compression-Fracture Implants
5.1.3.6. Sacroiliac Joint Fusion Implants
5.1.4. Trauma and Craniomaxillofacial Implants
5.1.4.1. Plates and Screws
5.1.4.2. Intramedullary Nails
5.1.4.3. External Fixation Systems
5.1.4.4. Hip-Fracture Fixation Implants
5.1.4.5. Pelvic and Acetabular Fixation Implants
5.1.4.6. Craniomaxillofacial Fixation Implants
5.1.5. Sports Medicine and Soft-Tissue Fixation Implants
5.1.5.1. Suture Anchors
5.1.5.2. Interference Screws
5.1.5.3. Cortical Buttons
5.1.5.4. Meniscal Repair Implants
5.1.5.5. Ligament and Tendon Fixation Devices
5.1.6. Extremity and Specialty Implants
5.1.6.1. Foot and Ankle Implants
5.1.6.2. Hand and Wrist Implants
5.1.6.3. Limb-Lengthening Implants
5.1.6.4. Oncology and Limb-Salvage Implants
5.1.6.5. Patient-Specific and Custom Reconstruction Implants

What this section provides: This section identifies the orthopedic implant categories expected to generate the highest revenue, procedure-linked demand, and strongest growth through 2035.

6. U.S. Orthopedic Implants Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Osteoarthritis and Degenerative Joint Disease
6.1.2.1. Knee Osteoarthritis
6.1.2.2. Hip Osteoarthritis
6.1.2.3. Shoulder Arthritis
6.1.2.4. Post-Traumatic Arthritis
6.1.3. Degenerative Spine Disease and Deformity
6.1.3.1. Degenerative Disc Disease
6.1.3.2. Spinal Stenosis
6.1.3.3. Spondylolisthesis
6.1.3.4. Adult Spinal Deformity
6.1.3.5. Cervical Spine Disorders
6.1.4. Fractures and Acute Trauma
6.1.4.1. Hip and Femoral Fractures
6.1.4.2. Tibial and Ankle Fractures
6.1.4.3. Upper-Extremity Fractures
6.1.4.4. Pelvic and Acetabular Trauma
6.1.4.5. Craniomaxillofacial Trauma
6.1.5. Sports Injuries and Soft-Tissue Repair
6.1.5.1. Anterior Cruciate Ligament Reconstruction
6.1.5.2. Rotator Cuff Repair
6.1.5.3. Meniscal Repair
6.1.5.4. Labral Repair
6.1.5.5. Tendon and Ligament Reconstruction
6.1.6. Revision and Complex Reconstruction
6.1.6.1. Aseptic Loosening and Implant Wear
6.1.6.2. Periprosthetic Joint Infection
6.1.6.3. Implant Instability and Dislocation
6.1.6.4. Periprosthetic Fracture
6.1.6.5. Bone-Loss and Custom Reconstruction

What this section provides: This section helps clients understand implant demand by clinical use case and prioritize applications with strong procedure growth, reimbursement relevance, implant intensity, and revision potential.

7. U.S. Orthopedic Implants Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Hospitals and Integrated Health Systems
7.1.2.1. Large Integrated Delivery Networks
7.1.2.2. Community Hospitals
7.1.2.3. Regional Referral Hospitals
7.1.3. Ambulatory Surgery Centers
7.1.3.1. Hospital-Owned ASCs
7.1.3.2. Physician-Owned ASCs
7.1.3.3. Independent Multi-Specialty ASCs
7.1.4. Orthopedic Specialty Hospitals and Physician-Owned Facilities
7.1.5. Academic Medical Centers and Trauma Centers
7.1.5.1. Academic Orthopedic Centers
7.1.5.2. Level I and Level II Trauma Centers
7.1.5.3. Complex Revision and Reconstruction Centers
7.1.6. Orthopedic Clinics and Other Care Settings
7.1.6.1. Large Orthopedic Group Practices
7.1.6.2. Sports Medicine Clinics
7.1.6.3. Veterans Health Administration Facilities
7.1.6.4. Military Medical Facilities

What this section provides: This section explains which care settings and customer groups are expected to drive implant purchasing, procedure migration, vendor selection, and recurring demand.

8. U.S. Orthopedic Implants Market – By Material Type

8.1. Overview
8.1.1. Segment Share Analysis, By Material Type, 2025 & 2035 (%)
8.1.2. Titanium and Titanium Alloys
8.1.2.1. Solid Titanium Implants
8.1.2.2. Porous Titanium Implants
8.1.2.3. Additively Manufactured Titanium Implants
8.1.3. Cobalt-Chromium and Stainless-Steel Alloys
8.1.3.1. Cobalt-Chromium Alloys
8.1.3.2. Medical-Grade Stainless Steel
8.1.4. Ceramic Materials
8.1.4.1. Alumina Ceramics
8.1.4.2. Zirconia-Toughened Ceramics
8.1.4.3. Ceramic-Coated Components
8.1.5. Polymeric Materials
8.1.5.1. Highly Cross-Linked Polyethylene
8.1.5.2. Polyether Ether Ketone
8.1.5.3. Other Medical-Grade Polymers
8.1.6. Bioresorbable, Composite, and Advanced Porous Materials
8.1.6.1. Bioresorbable Polymers
8.1.6.2. Biocomposite Materials
8.1.6.3. Carbon-Fiber-Reinforced Materials
8.1.6.4. Porous and Trabecular Structures
8.1.6.5. Bioactive and Antimicrobial Coatings

What this section provides: This section evaluates the implant materials shaping fixation, wear performance, osseointegration, imaging compatibility, manufacturing economics, and next-generation product development.

9. U.S. Orthopedic Implants Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.4. Group Purchasing Organization Contracts
9.1.5. Distributor and Specialty Supplier Sales
9.1.6. Ambulatory Surgery Center and Physician-Owned Facility Procurement
9.1.7. Trauma Consignment and Loaner Inventory Models
9.1.8. Capital Placement and Implant Pull-Through Agreements
9.1.9. Bundled Procedure and Episode-Based Contracts

What this section provides: This section explains how orthopedic implants are purchased in the U.S., including hospital contracting, IDN standardization, GPO influence, distributor coverage, consignment inventory, ASC procurement, and capital-linked implant agreements.

10. U.S. Orthopedic Implants Market – By Geography
10.1. Introduction

10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Orthopedic Procedure Volume and Surgical Infrastructure Analysis
10.1.4. Regional Arthritis, Aging, Trauma, and Spine Disease Burden
10.1.5. Regional Ambulatory Surgery Center Penetration
10.1.6. Regional Reimbursement and Procurement Dynamics

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Orthopedic Implant Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California

10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington

10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona

10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado

10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon

10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah

10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada

10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico

10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho

10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana

10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming

10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska

10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii

10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Orthopedic Implant Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York

10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts

10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey

10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania

10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut

10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine

10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont

10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire

10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island

10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.18. Delaware

10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Orthopedic Implant Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas

10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida

10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia

10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina

10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee

10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina

10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama

10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi

10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana

10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas

10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky

10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma

10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia

10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland

10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia

10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Orthopedic Implant Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois

10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio

10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan

10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota

10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana

10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin

10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri

10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa

10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas

10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska

10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota

10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota

10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level analysis across all 50 states, helping clients identify procedure-volume hubs, demographic demand pockets, outpatient adoption hotspots, hospital procurement patterns, and state-level commercial opportunities.

11. U.S. Orthopedic Implants Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Market Concentration Analysis
11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Emerging Players
11.4. Product Portfolio Benchmarking
11.5. Robotic and Enabling Technology Positioning
11.6. Merger, Acquisition, and Partnership Analysis
11.7. Company Profiles
11.7.1. DePuy Synthes, a Johnson & Johnson MedTech Business
11.7.2. Stryker Corporation
11.7.3. Zimmer Biomet Holdings
11.7.4. Smith+Nephew
11.7.5. Medtronic
11.7.6. Globus Medical
11.7.7. Enovis Corporation
11.7.8. Arthrex
11.7.9. Integra LifeSciences
11.7.10. Orthofix Medical
11.7.11. CONMED Corporation
11.7.12. Aesculap, a B. Braun Company
11.7.13. Acumed, a Colson Medical Company
11.7.14. Exactech
11.7.15. MicroPort Orthopedics
11.7.16. Corin Group
11.7.17. SI-BONE
11.7.18. Alphatec Holdings
11.7.19. Highridge Medical
11.7.20. restor3d
11.7.21. Treace Medical Concepts
11.7.22. Skeletal Dynamics
11.7.23. Tyber Medical
11.7.24. Curiteva
11.7.25. Aurora Spine

Note: Each company profile will include company overview, orthopedic implant portfolio, U.S. market strategy, financial positioning, product pipeline, robotic or enabling technology capabilities, regulatory updates, partnerships, acquisitions, and recent developments.

What this section provides: This section gives clients competitor benchmarking, market-share visibility, portfolio positioning, robotic and digital strategy, innovation direction, acquisition activity, and strategic intelligence on major orthopedic implant companies.

12. U.S. Orthopedic Implants Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Robotic-Assisted Orthopedic Surgery
12.2.2. Navigation and Augmented-Reality Guidance
12.2.3. 3D-Printed and Patient-Specific Implants
12.2.4. Smart and Sensor-Enabled Implants
12.2.5. Advanced Porous Materials and Osseointegration
12.2.6. Antimicrobial and Infection-Resistant Implant Surfaces
12.2.7. Minimally Invasive Spine Systems
12.2.8. Outpatient-Optimized Implant and Instrument Platforms
12.3. Emerging Business Trends
12.3.1. Implant Platform Consolidation
12.3.2. Capital Placement and Implant Pull-Through
12.3.3. Procedure Bundling and Episode-Based Contracting
12.3.4. Direct-to-ASC Commercial Models
12.3.5. Data-Driven Post-Operative Monitoring
12.3.6. Personalized Orthopedic Reconstruction
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.6. Product Category Opportunity Matrix
12.7. State and Regional Expansion Opportunity Matrix

What this section provides: This section prepares clients for future technology shifts, market-structure changes, outpatient migration, investment opportunities, and potential orthopedic implant adoption scenarios through 2035.

13. U.S. Orthopedic Implants Market: Strategic Recommendations

13.1. Recommendations for Orthopedic Implant Manufacturers
13.2. Recommendations for Hospitals and Integrated Health Systems
13.3. Recommendations for Ambulatory Surgery Centers
13.4. Recommendations for Investors and Private Equity Firms
13.5. Recommendations for Distributors and Channel Partners
13.6. Recommendations for New Entrants and Startups
13.7. Go-to-Market Strategy Considerations
13.7.1. Hospital and IDN Market Entry
13.7.2. ASC and Physician-Owned Facility Market Entry
13.7.3. Trauma and Emergency Inventory Strategy
13.7.4. Surgeon Training and Clinical Education Strategy
13.7.5. Regional Distributor and Direct-Sales Strategy
13.8. Product Positioning and Portfolio Expansion Guidance
13.8.1. Joint Reconstruction Portfolio Strategy
13.8.2. Spine Portfolio Strategy
13.8.3. Trauma Portfolio Strategy
13.8.4. Sports Medicine and Extremity Strategy
13.8.5. Robotics and Digital Enabling Technology Strategy
13.9. Pricing and Contracting Recommendations
13.10. Merger, Acquisition, and Partnership Priorities

What this section provides: This section converts market intelligence into actionable strategy for product development, market entry, contracting, hospital and ASC expansion, portfolio positioning, investment decisions, and competitive differentiation.

14. U.S. Orthopedic Implants Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
14.6. Procedure-Volume Estimation Limitation
14.7. State-Level Market Estimation Limitation
14.8. Regulatory and Reimbursement Change Limitation

What this section provides: This section clarifies the report’s scope, limitations, legal boundaries, state-level modeling constraints, data-use terms, and forecasting assumptions.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Orthopedic Implants Market: Market Definition and Scope
TABLE 3: U.S. Orthopedic Implants Market: Research Methodology Framework
TABLE 4: U.S. Orthopedic Implants Market: Bottom-Up and Top-Down Market Estimation Framework
TABLE 5: U.S. Orthopedic Implants Market: Procedure-Volume and Implant-Utilization Modeling Framework
TABLE 6: U.S. Orthopedic Implants Market: Key Assumptions
TABLE 7: U.S. Orthopedic Implants Market: Market Ecosystem Overview
TABLE 8: U.S. Orthopedic Implants Market: Stakeholder Analysis
TABLE 9: U.S. Orthopedic Implants Market: Executive Summary Snapshot, 2025
TABLE 10: U.S. Orthopedic Implants Market: Analyst Viewpoint Summary
TABLE 11: U.S. Orthopedic Implants Market: Market Attractiveness Index
TABLE 12: U.S. Orthopedic Implants Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 13: U.S. Orthopedic Implants Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 14: U.S. Orthopedic Implants Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 15: U.S. Orthopedic Implants Market: High-Growth Product, Application and Regional Opportunities
TABLE 16: U.S. Orthopedic Implants Market: Drivers; Impact Analysis
TABLE 17: U.S. Orthopedic Implants Market: Restraints; Impact Analysis
TABLE 18: U.S. Orthopedic Implants Market: Opportunities; Impact Analysis
TABLE 19: U.S. Orthopedic Implants Market: Challenges; Impact Analysis
TABLE 20: U.S. Orthopedic Implants Market: Patent & Innovation Analysis, 2021–2025
TABLE 21: U.S. Orthopedic Implants Market: Clinical Workflow Economics Matrix
TABLE 22: U.S. Orthopedic Implants Market: Implant Cost, OR Time and Sterile Processing Economics
TABLE 23: U.S. Orthopedic Implants Market: Hospital Capital Procurement Behavior Matrix
TABLE 24: U.S. Orthopedic Implants Market: Robotic Platform Placement and Implant Pull-Through Analysis
TABLE 25: U.S. Orthopedic Implants Market: PESTEL Analysis
TABLE 26: U.S. Orthopedic Implants Market: Porter’s Five Forces Analysis
TABLE 27: U.S. Orthopedic Implants Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 28: U.S. Orthopedic Implants Market: Implant Average Selling Price Analysis
TABLE 29: U.S. Orthopedic Implants Market: Value Chain Analysis
TABLE 30: U.S. Orthopedic Implants Market: Supply Chain Analysis
TABLE 31: U.S. Orthopedic Implants Market: Robotics, Navigation and Digitalization Impact
TABLE 32: U.S. Orthopedic Implants Market: Application & Innovation Landscape
TABLE 33: U.S. Orthopedic Implants Market: FDA Regulatory Framework Analysis
TABLE 34: U.S. Orthopedic Implants Market: CMS Reimbursement and Coverage Landscape
TABLE 35: U.S. Orthopedic Implants Market: Import/Export Restrictions & Tariff Impact
TABLE 36: U.S. Orthopedic Implants Market: Government Initiatives and Musculoskeletal Health Programs
TABLE 37: U.S. Orthopedic Implants Market: Impact of Escalating Geopolitical Tensions
TABLE 38: U.S. Orthopedic Implants Market: Hospital Value Analysis Committee Decision Framework
TABLE 39: U.S. Orthopedic Implants Market: Product Category Snapshot, 2025
TABLE 40: Segment Dashboard; Definition and Scope, by Product Category
TABLE 41: U.S. Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 42: U.S. Orthopedic Implants Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 43: U.S. Orthopedic Implants Market: Joint Reconstruction Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: U.S. Orthopedic Implants Market: Spinal Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: U.S. Orthopedic Implants Market: Trauma and Craniomaxillofacial Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. Orthopedic Implants Market: Sports Medicine and Soft-Tissue Fixation Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Orthopedic Implants Market: Extremity and Specialty Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Orthopedic Implants Market: Application Snapshot, 2025
TABLE 49: Segment Dashboard; Definition and Scope, by Application
TABLE 50: U.S. Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 51: U.S. Orthopedic Implants Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 52: U.S. Orthopedic Implants Market: Osteoarthritis and Degenerative Joint Disease Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Orthopedic Implants Market: Degenerative Spine Disease and Deformity Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Orthopedic Implants Market: Fractures and Acute Trauma Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Orthopedic Implants Market: Sports Injuries and Soft-Tissue Repair Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Orthopedic Implants Market: Revision and Complex Reconstruction Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Orthopedic Implants Market: End User Snapshot, 2025
TABLE 58: Segment Dashboard; Definition and Scope, by End User
TABLE 59: U.S. Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 60: U.S. Orthopedic Implants Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 61: U.S. Orthopedic Implants Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Orthopedic Implants Market: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Orthopedic Implants Market: Orthopedic Specialty Hospitals and Physician-Owned Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. Orthopedic Implants Market: Academic Medical Centers and Trauma Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Orthopedic Implants Market: Orthopedic Clinics and Other Care Settings Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Orthopedic Implants Market: Material Type Snapshot, 2025
TABLE 67: Segment Dashboard; Definition and Scope, by Material Type
TABLE 68: U.S. Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 69: U.S. Orthopedic Implants Market: Segment Share Analysis, by Material Type, 2025 & 2035 (%)
TABLE 70: U.S. Orthopedic Implants Market: Titanium and Titanium Alloys Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: U.S. Orthopedic Implants Market: Cobalt-Chromium and Stainless-Steel Alloys Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. Orthopedic Implants Market: Ceramic Materials Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. Orthopedic Implants Market: Polymeric Materials Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Orthopedic Implants Market: Bioresorbable, Composite and Advanced Porous Materials Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Orthopedic Implants Market: Procurement Channel Snapshot, 2025
TABLE 76: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 77: U.S. Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 78: U.S. Orthopedic Implants Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 79: U.S. Orthopedic Implants Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: U.S. Orthopedic Implants Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: U.S. Orthopedic Implants Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. Orthopedic Implants Market: Distributor and Specialty Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. Orthopedic Implants Market: Ambulatory Surgery Center and Physician-Owned Facility Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. Orthopedic Implants Market: Trauma Consignment and Loaner Inventory Models Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: U.S. Orthopedic Implants Market: Capital Placement and Implant Pull-Through Agreements Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: U.S. Orthopedic Implants Market: Bundled Procedure and Episode-Based Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 87: U.S. Orthopedic Implants Market: Regional Snapshot, 2025
TABLE 88: Segment Dashboard; Definition and Scope, by Region
TABLE 89: U.S. Orthopedic Implants Market, by Region, 2021–2035 (US$ Billion)
TABLE 90: U.S. Orthopedic Implants Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 91: West Region U.S. Orthopedic Implants Market: Regional Overview and Trends
TABLE 92: West Region U.S. Orthopedic Implants Market: Key Manufacturers and Procurement Ecosystem
TABLE 93: West Region U.S. Orthopedic Implants Market, by State, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 96: West Region U.S. Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 97: West Region U.S. Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 98: West Region U.S. Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 99: California Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 100: California Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 101: California Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 102: California Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 103: California Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 104: Washington Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 105: Washington Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 106: Washington Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 107: Washington Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 108: Washington Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 109: Arizona Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 110: Arizona Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 111: Arizona Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 112: Arizona Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 113: Arizona Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 114: Colorado Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 115: Colorado Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 116: Colorado Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 117: Colorado Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 118: Colorado Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 119: Oregon Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 120: Oregon Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 121: Oregon Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 122: Oregon Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 123: Oregon Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 124: Utah Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 125: Utah Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 126: Utah Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 127: Utah Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 128: Utah Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 129: Nevada Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 130: Nevada Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 131: Nevada Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 132: Nevada Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 133: Nevada Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 134: New Mexico Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 135: New Mexico Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 136: New Mexico Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 137: New Mexico Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 138: New Mexico Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 139: Idaho Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 140: Idaho Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 141: Idaho Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 142: Idaho Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 143: Idaho Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 144: Montana Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 145: Montana Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 146: Montana Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 147: Montana Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 148: Montana Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 149: Wyoming Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 150: Wyoming Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 151: Wyoming Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 152: Wyoming Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 153: Wyoming Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 154: Alaska Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 155: Alaska Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 156: Alaska Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 157: Alaska Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 158: Alaska Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 159: Hawaii Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 160: Hawaii Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 161: Hawaii Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 162: Hawaii Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 163: Hawaii Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 164: Northeast Region U.S. Orthopedic Implants Market: Regional Overview and Trends
TABLE 165: Northeast Region U.S. Orthopedic Implants Market: Key Manufacturers and Procurement Ecosystem
TABLE 166: Northeast Region U.S. Orthopedic Implants Market, by State, 2021–2035 (US$ Billion)
TABLE 167: Northeast Region U.S. Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 168: Northeast Region U.S. Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 169: Northeast Region U.S. Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 170: Northeast Region U.S. Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 171: Northeast Region U.S. Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 172: New York Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 173: New York Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 174: New York Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 175: New York Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 176: New York Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 177: Massachusetts Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 178: Massachusetts Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 179: Massachusetts Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 180: Massachusetts Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 181: Massachusetts Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 182: New Jersey Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 183: New Jersey Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 184: New Jersey Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 185: New Jersey Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 186: New Jersey Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 187: Pennsylvania Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 188: Pennsylvania Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 189: Pennsylvania Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 190: Pennsylvania Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 191: Pennsylvania Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 192: Connecticut Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 193: Connecticut Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 194: Connecticut Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 195: Connecticut Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 196: Connecticut Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 197: Maine Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 198: Maine Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 199: Maine Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 200: Maine Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 201: Maine Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 202: Vermont Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 203: Vermont Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 204: Vermont Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 205: Vermont Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 206: Vermont Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 207: New Hampshire Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 208: New Hampshire Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 209: New Hampshire Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 210: New Hampshire Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 211: New Hampshire Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 212: Rhode Island Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 213: Rhode Island Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 214: Rhode Island Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 215: Rhode Island Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 216: Rhode Island Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 217: Delaware Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 218: Delaware Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 219: Delaware Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 220: Delaware Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 221: Delaware Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 222: South Region U.S. Orthopedic Implants Market: Regional Overview and Trends
TABLE 223: South Region U.S. Orthopedic Implants Market: Key Manufacturers and Procurement Ecosystem
TABLE 224: South Region U.S. Orthopedic Implants Market, by State, 2021–2035 (US$ Billion)
TABLE 225: South Region U.S. Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 226: South Region U.S. Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 227: South Region U.S. Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 228: South Region U.S. Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 229: South Region U.S. Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 230: Texas Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 231: Texas Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 232: Texas Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 233: Texas Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 234: Texas Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 235: Florida Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 236: Florida Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 237: Florida Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 238: Florida Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 239: Florida Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 240: Georgia Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 241: Georgia Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 242: Georgia Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 243: Georgia Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 244: Georgia Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 245: North Carolina Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 246: North Carolina Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 247: North Carolina Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 248: North Carolina Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 249: North Carolina Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 250: Tennessee Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 251: Tennessee Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 252: Tennessee Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 253: Tennessee Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 254: Tennessee Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 255: South Carolina Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 256: South Carolina Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 257: South Carolina Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 258: South Carolina Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 259: South Carolina Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 260: Alabama Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 261: Alabama Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 262: Alabama Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 263: Alabama Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 264: Alabama Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 265: Mississippi Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 266: Mississippi Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 267: Mississippi Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 268: Mississippi Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 269: Mississippi Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 270: Louisiana Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 271: Louisiana Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 272: Louisiana Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 273: Louisiana Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 274: Louisiana Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 275: Arkansas Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 276: Arkansas Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 277: Arkansas Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 278: Arkansas Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 279: Arkansas Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 280: Kentucky Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 281: Kentucky Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 282: Kentucky Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 283: Kentucky Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 284: Kentucky Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 285: Oklahoma Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 286: Oklahoma Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 287: Oklahoma Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 288: Oklahoma Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 289: Oklahoma Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 290: Virginia Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 291: Virginia Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 292: Virginia Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 293: Virginia Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 294: Virginia Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 295: Maryland Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 296: Maryland Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 297: Maryland Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 298: Maryland Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 299: Maryland Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 300: West Virginia Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 301: West Virginia Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 302: West Virginia Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 303: West Virginia Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 304: West Virginia Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 305: Midwest Region U.S. Orthopedic Implants Market: Regional Overview and Trends
TABLE 306: Midwest Region U.S. Orthopedic Implants Market: Key Manufacturers and Procurement Ecosystem
TABLE 307: Midwest Region U.S. Orthopedic Implants Market, by State, 2021–2035 (US$ Billion)
TABLE 308: Midwest Region U.S. Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 309: Midwest Region U.S. Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 310: Midwest Region U.S. Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 311: Midwest Region U.S. Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 312: Midwest Region U.S. Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 313: Illinois Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 314: Illinois Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 315: Illinois Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 316: Illinois Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 317: Illinois Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 318: Ohio Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 319: Ohio Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 320: Ohio Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 321: Ohio Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 322: Ohio Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 323: Michigan Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 324: Michigan Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 325: Michigan Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 326: Michigan Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 327: Michigan Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 328: Minnesota Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 329: Minnesota Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 330: Minnesota Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 331: Minnesota Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 332: Minnesota Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 333: Indiana Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 334: Indiana Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 335: Indiana Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 336: Indiana Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 337: Indiana Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 338: Wisconsin Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 339: Wisconsin Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 340: Wisconsin Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 341: Wisconsin Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 342: Wisconsin Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 343: Missouri Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 344: Missouri Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 345: Missouri Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 346: Missouri Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 347: Missouri Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 348: Iowa Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 349: Iowa Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 350: Iowa Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 351: Iowa Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 352: Iowa Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 353: Kansas Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 354: Kansas Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 355: Kansas Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 356: Kansas Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 357: Kansas Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 358: Nebraska Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 359: Nebraska Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 360: Nebraska Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 361: Nebraska Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 362: Nebraska Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 363: North Dakota Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 364: North Dakota Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 365: North Dakota Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 366: North Dakota Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 367: North Dakota Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 368: South Dakota Orthopedic Implants Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 369: South Dakota Orthopedic Implants Market, by Application, 2021–2035 (US$ Billion)
TABLE 370: South Dakota Orthopedic Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 371: South Dakota Orthopedic Implants Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 372: South Dakota Orthopedic Implants Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 373: U.S. Orthopedic Implants Market: Competitive Landscape Snapshot, 2025
TABLE 374: U.S. Orthopedic Implants Market: Key Company Market Share Analysis, 2025
TABLE 375: U.S. Orthopedic Implants Market: Market Concentration Analysis
TABLE 376: U.S. Orthopedic Implants Market: Company Positioning Matrix
TABLE 377: U.S. Orthopedic Implants Market: Product Portfolio Benchmarking of Key Players
TABLE 378: U.S. Orthopedic Implants Market: Robotic and Enabling Technology Positioning
TABLE 379: U.S. Orthopedic Implants Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 380: DePuy Synthes: Company Profile
TABLE 381: Stryker Corporation: Company Profile
TABLE 382: Zimmer Biomet Holdings: Company Profile
TABLE 383: Smith+Nephew: Company Profile
TABLE 384: Medtronic: Company Profile
TABLE 385: Globus Medical: Company Profile
TABLE 386: Enovis Corporation: Company Profile
TABLE 387: Arthrex: Company Profile
TABLE 388: Integra LifeSciences: Company Profile
TABLE 389: Orthofix Medical: Company Profile
TABLE 390: CONMED Corporation: Company Profile
TABLE 391: Aesculap, a B. Braun Company: Company Profile
TABLE 392: Acumed, a Colson Medical Company: Company Profile
TABLE 393: Exactech: Company Profile
TABLE 394: MicroPort Orthopedics: Company Profile
TABLE 395: Corin Group: Company Profile
TABLE 396: SI-BONE: Company Profile
TABLE 397: Alphatec Holdings: Company Profile
TABLE 398: Highridge Medical: Company Profile
TABLE 399: restor3d: Company Profile
TABLE 400: Treace Medical Concepts: Company Profile
TABLE 401: Skeletal Dynamics: Company Profile
TABLE 402: Tyber Medical: Company Profile
TABLE 403: Curiteva: Company Profile
TABLE 404: Aurora Spine: Company Profile
TABLE 405: U.S. Orthopedic Implants Market: Future Market Scenario Analysis, 2026–2035
TABLE 406: U.S. Orthopedic Implants Market: Disruptive Technologies Impact Matrix
TABLE 407: U.S. Orthopedic Implants Market: Emerging Business Trends
TABLE 408: U.S. Orthopedic Implants Market: Business Opportunities for Startups and Existing Players
TABLE 409: U.S. Orthopedic Implants Market: Investment Prioritization Matrix
TABLE 410: U.S. Orthopedic Implants Market: Product Category Opportunity Matrix
TABLE 411: U.S. Orthopedic Implants Market: State and Regional Expansion Opportunity Matrix
TABLE 412: U.S. Orthopedic Implants Market: Strategic Recommendations for Implant Manufacturers
TABLE 413: U.S. Orthopedic Implants Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 414: U.S. Orthopedic Implants Market: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 415: U.S. Orthopedic Implants Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 416: U.S. Orthopedic Implants Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 417: U.S. Orthopedic Implants Market: Strategic Recommendations for New Entrants and Startups
TABLE 418: U.S. Orthopedic Implants Market: Go-to-Market Strategy Considerations
TABLE 419: U.S. Orthopedic Implants Market: Product Positioning and Portfolio Expansion Guidance
TABLE 420: U.S. Orthopedic Implants Market: Pricing and Contracting Recommendations
TABLE 421: U.S. Orthopedic Implants Market: Merger, Acquisition and Partnership Priorities
TABLE 422: U.S. Orthopedic Implants Market: Scope Limitation
TABLE 423: U.S. Orthopedic Implants Market: Data Use Limitation
TABLE 424: U.S. Orthopedic Implants Market: Forecasting Limitation
TABLE 425: U.S. Orthopedic Implants Market: Legal Disclaimer
TABLE 426: U.S. Orthopedic Implants Market: Third-Party Data Disclaimer
TABLE 427: U.S. Orthopedic Implants Market: Procedure-Volume Estimation Limitation
TABLE 428: U.S. Orthopedic Implants Market: State-Level Market Estimation Limitation
TABLE 429: U.S. Orthopedic Implants Market: Regulatory and Reimbursement Change Limitation

List of Figures

FIGURE 1: U.S. Orthopedic Implants Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Bottom-Up and Top-Down Market Estimation Framework
FIGURE 4: Procedure-Volume and Implant-Utilization Modeling Framework
FIGURE 5: Value Chain Analysis
FIGURE 6: Supply Chain Analysis
FIGURE 7: PESTEL Analysis
FIGURE 8: Porter’s Five Forces Analysis
FIGURE 9: Market Attractiveness Analysis
FIGURE 10: Market Dynamics
FIGURE 11: Innovation & Patent Landscape, 2021–2025
FIGURE 12: Clinical Workflow Economics Framework
FIGURE 13: Hospital Capital Procurement Decision Framework
FIGURE 14: U.S. Orthopedic Implants Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 15: U.S. Orthopedic Implants Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 16: U.S. Orthopedic Implants Market Year-wise Growth Curve, 2021–2035
FIGURE 17: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 18: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Joint Reconstruction Implants Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Spinal Implants Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Trauma and Craniomaxillofacial Implants Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Sports Medicine and Soft-Tissue Fixation Implants Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Extremity and Specialty Implants Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 25: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Osteoarthritis and Degenerative Joint Disease Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Degenerative Spine Disease and Deformity Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Fractures and Acute Trauma Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Sports Injuries and Soft-Tissue Repair Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Revision and Complex Reconstruction Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 32: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Orthopedic Specialty Hospitals and Physician-Owned Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Academic Medical Centers and Trauma Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Orthopedic Clinics and Other Care Settings Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Material Type Segment Market Share Analysis, 2025 & 2035
FIGURE 39: Material Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Titanium and Titanium Alloys Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Cobalt-Chromium and Stainless-Steel Alloys Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Ceramic Materials Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Polymeric Materials Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Bioresorbable, Composite and Advanced Porous Materials Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 46: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Distributor and Specialty Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Ambulatory Surgery Center and Physician-Owned Facility Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Trauma Consignment and Loaner Inventory Models Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Capital Placement and Implant Pull-Through Agreements Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Bundled Procedure and Episode-Based Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 56: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: West Region U.S. Orthopedic Implants Market Share and Leading Players, 2025
FIGURE 58: West Region Market Share Analysis by State, 2025
FIGURE 59: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: California Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Washington Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Arizona Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Colorado Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Oregon Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Utah Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Nevada Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: New Mexico Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Idaho Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Montana Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Wyoming Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Alaska Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Hawaii Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Northeast Region U.S. Orthopedic Implants Market Share and Leading Players, 2025
FIGURE 74: Northeast Region Market Share Analysis by State, 2025
FIGURE 75: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: New York Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Massachusetts Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: New Jersey Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Pennsylvania Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Connecticut Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Maine Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Vermont Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: New Hampshire Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Rhode Island Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Delaware Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: South Region U.S. Orthopedic Implants Market Share and Leading Players, 2025
FIGURE 87: South Region Market Share Analysis by State, 2025
FIGURE 88: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Texas Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Florida Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Georgia Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: North Carolina Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Tennessee Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: South Carolina Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Alabama Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Mississippi Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Louisiana Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Arkansas Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Kentucky Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Oklahoma Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Virginia Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Maryland Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: West Virginia Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Midwest Region U.S. Orthopedic Implants Market Share and Leading Players, 2025
FIGURE 105: Midwest Region Market Share Analysis by State, 2025
FIGURE 106: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Illinois Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Ohio Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Michigan Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Minnesota Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Indiana Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Wisconsin Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Missouri Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Iowa Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Kansas Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Nebraska Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: North Dakota Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: South Dakota Orthopedic Implants Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 120: Market Concentration Analysis
FIGURE 121: Company Positioning Matrix
FIGURE 122: Key Player Product Portfolio Benchmarking
FIGURE 123: Robotic and Enabling Technology Positioning
FIGURE 124: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 125: Orthopedic Implant Innovation Roadmap
FIGURE 126: Robotic-Assisted Orthopedic Surgery Adoption Roadmap
FIGURE 127: 3D-Printed and Patient-Specific Implant Opportunity Map
FIGURE 128: Smart and Sensor-Enabled Implant Development Roadmap
FIGURE 129: Outpatient Orthopedic Implant Growth Roadmap
FIGURE 130: Future Market Scenario Analysis, 2026–2035
FIGURE 131: Disruptive Technologies Impact Matrix
FIGURE 132: Emerging Business Trends Matrix
FIGURE 133: Investment Prioritization Matrix
FIGURE 134: Product Category Opportunity Matrix
FIGURE 135: State and Regional Expansion Opportunity Matrix
FIGURE 136: Strategic Growth Roadmap for U.S. Orthopedic Implant Companies
FIGURE 137: Go-to-Market Strategy Framework
FIGURE 138: Product Positioning and Portfolio Expansion Framework
FIGURE 139: Pricing and Contracting Strategy Framework
FIGURE 140: Report Scope and Disclaimer Framework